Brief: Relief And Advita Start Phase 2 Trial Of RLF-100 For Prevention Of Acute Respiratory Distress

MindMaze Therapeutics Holding SA

22/04/2021 06:09

April 22 (Reuters) - RELIEF THERAPEUTICS HOLDING SA
 RLFB.S :
    * RELIEF AND ADVITA ANNOUNCE INITIATION OF PHASE 2 TRIAL
WITH
INHALED RLF-100 FOR THE PREVENTION OF COVID-19-RELATED ACUTE
RESPIRATORY DISTRESS SYNDROME

Source text for Eikon:  ID:nNDL39fPzG 
Further company coverage:  RLFB.S 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))